Dr. Cherie S. Tan is an Associate Professor of Medical College at the Tianjin University. She was raised in Harbin, China, and California, US. Her undergraduate training was in analytical chemistry with Prof. Janusz Pawliszyn, a Fellow of the Royal Society of Canada, at the University of Waterloo.  After obtaining her Bachelor’s Degree in Canada, she moved back to California and spent four years working in the San Francisco Bay Area biotechnology industry. During that time, she developed her skills to become a senior Bioanalytical Scientist of DMPK department (Drug Metabolism Pharmacokinetics) at Novartis Institutes for BioMedical Research, the World's top 3 pharmaceutical company. In order to further understand the expression of cancer-related genes and developed an analytical method for fast screening of the targeted genes, she pursued her Ph.D. degree in a Nanopore Sequencing of DNA Damage group, operated by Professor Cynthia J.Burrows, a fellow of the National Academy of Sciences, and Professor Henry White, a fellow of the American Academy of Arts and Sciences. Following a postdoctoral appointment at the same group, she began her academic career as an associate professor at Tianjin University in 2019.  

• Intelligent Biomedical Sensing 智能医学传感；Biomarker Detection 生物标志物检测；Single-Molecule Sensing 单分子传感；Interfacial Sensing 界面传感; DNA and RNA sequencing method development基因测序技术研发；Antigen detection 抗原检测技术研发；Point-to-Care Testing POCT检测
  

• 暂无内容